Injective Becomes the First Layer-1 Blockchain With an SEC-Registered Transfer Agent as Its Staked ETF Lists on Nasdaq

Injective has quietly assembled the most regulated tokenization stack of any Layer-1 blockchain — and this week the pieces clicked into place in public. Its affiliate, Injective Institutional Services, is registered with the U.S. Securities and Exchange Commission (SEC) as a transfer agent, making Injective the first Layer-1 blockchain ecosystem with that designation. Days later, Canary Capital launched the first U.S. ETF tracking Injective's INJ token on Nasdaq, a fund that plans to stake at least 90% of its holdings. For a chain built for finance, the message is clear: tokenization is moving from crypto-native experiments into regulated market infrastructure. The ETF debut was reported by The Block on November 5, with INJ rising more than 5% on the day.

What a transfer agent actually does — and why it matters

A transfer agent is one of the least glamorous and most essential jobs in traditional finance. It maintains the official record of who owns a security, processes transfers when ownership changes, and handles corporate actions such as dividend payments. Every share of a listed company sits on a transfer agent's books. Without one, a tokenized stock or fund is a claim with no recognised registry behind it.

That is exactly the gap Injective's registration closes. With a registered transfer agent inside its own ecosystem, Injective can keep official securities ownership records directly on-chain — the SEC has said a registered transfer agent may use distributed ledger technology as its official master securityholder file, provided it meets federal securities law requirements. In practice, that means a tokenized asset issued on Injective can have its ownership ledger recognised by the same rules that govern Wall Street's paperwork, rather than sitting in a parallel, unregulated system. Injective's CEO Eric Chen has described the transfer agent as "basically the very start" of the chain's U.S. licensing work — the foundation, not the finish line.

The ETF: staking yield inside a Nasdaq-listed wrapper

The second half of the week's news puts the registration to work. The Canary Staked INJ ETF (ticker INJC) launched on Nasdaq on November 5, giving traditional investors exposure to INJ's price and staking rewards without holding the token directly. The fund plans to stake at least 90% of its INJ on the network, with BitGo serving as custodian. Staking is the point: unlike a plain spot product, the ETF is designed to pass the network's staking yield through to shareholders, turning a Layer-1 token into an income-bearing instrument inside a brokerage account.

The market noticed. INJ climbed more than 5% on Thursday as the ETF news spread, a sharp contrast to a week in which Bitcoin slipped below $75,000 and most major tokens were under pressure. The move was modest in absolute terms, but the direction matters: in a risk-off tape, the token with a concrete institutional catalyst outperformed.

A tokenization stack years in the making

The transfer agent registration did not appear overnight. Injective's affiliate completed the registration in August 2026, and the chain has spent the months since building the regulated plumbing around it. The numbers behind the push are substantial: Injective says it has tokenized more than $1 billion in assets to date, processed over 3.13 billion transactions, and permanently burned more than 7.27 million INJ through its monthly token buybacks.

The pipeline behind those figures shows how broad the ambition is. Nomura's Laser Digital tokenized its Laser Carry Fund on Injective through Libre, alongside BlackRock money-market products and the Hamilton Lane SCOPE Senior Credit Fund. In July, POSCO International — South Korea's largest trading company — and LG CNS, the technology arm of LG Group, chose Injective for a live pilot that issues, transfers, administers and settles trade receivables from real international commerce. More than $1 billion in mortgage records has been tokenized on-chain, and publicly listed Pineapple Financial plans to tokenize over $10 billion on Injective in the coming months. A partnership with Korean custodian BDACS makes the KRW1 stablecoin the settlement asset for tokenized real-world assets in won, reducing reliance on dollar stablecoins.

Underneath it all sits the technology: the Meridian upgrade brought regulated token standards to Injective's EVM, unified multi-VM markets for tokenized assets, and the foundation for CypherOS, the chain's native privacy platform. A new white paper repositions Injective explicitly as a Layer-1 for institutional-grade finance, with a native real-world-asset tokenization mechanism, on-chain trading through a central limit order book, and high-frequency batch auctions designed to prevent front-running. In Europe, the Injective Foundation has completed the notification and publication process for the INJ MiCA white paper.

Why this is a blockchain story, not just a crypto price story

It is tempting to read this as another ETF headline. The deeper story is structural. Tokenization has spent years stuck at the same bottleneck: anyone can mint a token representing an asset, but the legal record of ownership — the part courts, auditors and regulators actually trust — still lived off-chain. A registered transfer agent operating on a blockchain collapses that distance. The chain stops being a parallel ledger and becomes the ledger of record.

That is also why the combination matters more than either piece alone. A transfer agent without products is plumbing with nothing flowing through it; an ETF without regulated recordkeeping is a wrapper around an unregistered asset. Injective now has both, plus the issuance platform — Injective Mint — that lets institutions issue compliance-ready tokenized assets without custom smart contracts. The pieces form a full stack: issue, trade, settle, record.

The same pattern is visible elsewhere in the industry. Amundi, Europe's largest asset manager, tokenized a European equity-index fund on Ethereum this cycle, and the race to put regulated funds on-chain is now running on multiple chains at once. What sets Injective apart is that it owns the regulated recordkeeping layer itself, rather than renting it from a third party.

What to watch next

• ETF flows. The first weeks of INJC trading will show whether traditional investors actually want staked INJ exposure — and whether the staking yield survives fees and costs.
• The transfer agent in action. Watch for the first tokenized security whose official ownership record is maintained on Injective. That is the moment the registration stops being a credential and starts being infrastructure.
• More licences. Chen's "very start" comment points to further U.S. registrations. Broker-dealer or clearing functions would be the natural next steps.
• The Pineapple test. A $10 billion tokenization plan from a listed company is the largest single commitment on the chain. Delivery, not announcement, is what counts.
• Competition. Ethereum, Solana and other chains are all courting the same issuers. Injective's edge is regulatory depth; its risk is that the biggest issuers still default to the biggest chains.

The bottom line

Injective's week is a template for where blockchain is heading: less about new tokens, more about regulated rails. A registered transfer agent, a staked ETF on Nasdaq, over $1 billion in tokenized assets and a $10 billion pipeline add up to a chain that is building the boring, necessary layer of finance — the recordkeeping — on-chain. If tokenization is going to move from pilot projects to real markets, it will need exactly this kind of infrastructure. Traders should watch INJC flows and the first on-chain transfer-agent records; the rest of the industry will be watching too. For a refresher on how to verify anything a chain claims, our guide on how to track any transaction with a blockchain explorer shows how to check the ledger yourself.

FAQ

What is a transfer agent? A transfer agent maintains the official record of who owns a security, processes ownership transfers, and handles corporate actions like dividend payments. It is a regulated function in U.S. securities markets.

Why does Injective's SEC registration matter? It makes Injective the first Layer-1 blockchain ecosystem with a registered transfer agent, so tokenized securities issued on the chain can have their official ownership records maintained on-chain under federal securities rules.

What is the Canary Staked INJ ETF (INJC)? The first U.S. ETF tracking Injective's INJ token, launched on Nasdaq on November 5, 2026. It plans to stake at least 90% of its INJ holdings, with BitGo as custodian, giving investors exposure to INJ plus staking rewards.

How much has Injective tokenized so far? More than $1 billion in assets, including funds from Nomura's Laser Digital, BlackRock money-market products and Hamilton Lane, plus over $1 billion in tokenized mortgage records.

Is INJ a good investment now? This article is market news and general information, not financial advice. The ETF launch and transfer-agent registration are real catalysts, but INJ remains a volatile crypto asset and the ETF's flows are unproven. Do your own research before investing, and follow verified market coverage on the Zimbuck News page and in the Zimbuck Market News group. Join the conversation on Zimbuck — the finance social platform for traders and investors.